Top

BMC Cardiovascular Disorders

Published in:

Open Access 01-12-2017 | Research article

Are women with type 2 diabetes mellitus more susceptible to cardiovascular complications following coronary angioplasty?: a meta-analysis

Authors: Pravesh Kumar Bundhun, Manish Pursun, Feng Huang

Published in: BMC Cardiovascular Disorders | Issue 1/2017

Abstract

Background

Scientific reports have shown Type 2 Diabetes Mellitus (T2DM) to be independently associated with adverse outcomes following Percutaneous Coronary Intervention (PCI). However, gender difference has also often been a controversial issue following PCI. Till date, very few meta-analyses have systematically compared the adverse cardiovascular outcomes in male versus female patients with T2DM following PCI. Therefore, we aimed to carry out this analysis in order to find out an answer to this interesting question.

Methods

Electronic databases were searched for English language publications reporting adverse cardiovascular outcomes in male versus female patients with diabetes mellitus respectively following coronary angioplasty. The RevMan 5.3 software was used to analyze selected adverse cardiovascular events whereby Odds Ratios (OR) and 95% Confidence Intervals (CI) were the statistical parameters.

Results

A total number of 19,304 patients with T2DM (12,986 male patients versus 6318 female patients) were included in this analysis. At baseline, female patients were older (68.7 versus 62.9 years), with a higher percentage of hypertension (75.6% versus 66.5%) and dyslipidemia (53.3% versus 50.0%) whereas majority of the male patients were smokers (46.3% versus 14.9%). Results of this analysis showed short and long-term mortality to be significantly higher in female patients with T2DM (OR: 1.71, 95% CI: 1.46–2.00; P = 0.00001), and (OR: 1.20, 95% CI: 1.07–1.35; P = 0.002) respectively. In addition, women were also more at risk for short and long-term major adverse cardiac events (MACEs) with OR: 1.49, 95% CI: 1.07–2.07; P = 0.02 and OR: 1.15, 95% CI: 1.04–1.28; P = 0.009 respectively. Subgroup analysis showed this significant result to have mainly been observed in patients with acute myocardial infarction compared to those with stable coronary artery disease.

Conclusions

Following PCI, women with T2DM were indeed more susceptible to short and long-term cardiovascular complications compared to male patients with the same chronic disease. Even though this result was more applicable to patients with acute myocardial infarction, the fact that women were older with higher co-morbidities at baseline compared to men, should also not be ignored.

Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.CrossRefPubMed

Li N, Yang YG, Chen MH. Comparing the adverse clinical outcomes in patients with non-insulin treated type 2 diabetes mellitus and patients without type 2 diabetes mellitus following percutaneous coronary intervention: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2016;16(1):238.CrossRefPubMedPubMedCentral

Naito R, Miyauchi K, Konishi H, Tsuboi S, Ogita M, Dohi T, Kasai T, Tamura H, Okazaki S, Isoda K, Daida H. Gender difference in long-term clinical outcomes following percutaneous coronary intervention during 1984-2008. Atherosclerosis. 2016;247:105–10.CrossRefPubMed

de Boer SP, Roos-Hesselink JW, van Leeuwen MA, Lenzen MJ, van Geuns RJ, Regar E, van Mieghem NM, van Domburg R, Zijlstra F, Serruys PW, Boersma E. Excess mortality in women compared to men after PCI in STEMI: an analysis of 11,931 patients during 2000-2009. Int J Cardiol. 2014;176(2):456–63.

Sotomi Y, Onuma Y, Cavalcante R, et al. Geographical Difference of the Interaction of Sex With Treatment Strategy in Patients With Multivessel Disease and Left Main Disease: A Meta-Analysis From SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery), PRECOMBAT (Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease), and BEST (Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients With Multivessel Coronary Artery Disease) Randomized Controlled Trials. Circ Cardiovasc Interv. 2017;10(5):e005027.

Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcareinterventions: explanation and elaboration. BMJ. 2009;339:b2700.CrossRefPubMedPubMedCentral

Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.CrossRefPubMedPubMedCentral

Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.CrossRefPubMedPubMedCentral

Blöndal M, Ainla T, Marandi T, Baburin A, Eha J. Sex-specific outcomes of diabetic patients with acute myocardial infarction who have undergonepercutaneous coronary intervention: a register linkage study. Cardiovasc Diabetol. 2012;11:96.CrossRefPubMedPubMedCentral

10.

Roffi M, Radovanovic D, Erne P, Urban P, Windecker S, Eberli FR. AMIS plus investigator. Gender-related mortality trends among diabetic patients with ST-segment elevation myocardialinfarction: insights from a nationwide registry 1997-2010. Eur Heart J Acute Cardiovasc Care. 2013;2(4):342–9.CrossRefPubMedPubMedCentral

11.

Liu HL, Liu Y, Hao ZX, Geng GY, Zhang ZF, Jing SB, Ba N, Guo W. Comparison of primary coronary percutaneous coronary intervention between diabetic men and women with acute myocardial infarction. Pak J Med Sci. 2015;31(2):420–5.CrossRefPubMedPubMedCentral

12.

Tamis-Holland JE, Lu J, Korytkowski M, Magee M, Rogers WJ, Lopes N, Mighton L, Jacobs AK. BARI 2D study group. Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D trial (bypass angioplasty revascularization investigation 2 diabetes). J Am Coll Cardiol. 2013;61(17):1767–76.CrossRefPubMed

13.

Baber U, Giustino G, Sartori S, et al. Effect of chronic kidney disease in women undergoing percutaneous coronary intervention with drug-eluting stents: a patient-level pooled analysis of randomized controlled trials. JACC Cardiovasc Interv. 2016;9(1):28–38.CrossRefPubMed

14.

Kautzky-Willer A, Kamyar MR, Gerhat D, Handisurya A, Stemer G, Hudson S, Luger A, Lemmens-Gruber R. Sex-specific differences in metabolic control, cardiovascular risk, and interventions in patients with type2 diabetes mellitus. Gend Med. 2010;7(6):571–83.CrossRefPubMed

15.

Champney KP, Veledar E, Klein M, Samady H, Anderson D, Parashar S, Wenger N, Vaccarino V. Sex-specific effects of diabetes on adverse outcomes after percutaneous coronary intervention: trends over time. Am Heart J. 2007;153(6):970–8.CrossRefPubMed

16.

Conrotto F, D'Ascenzo F, Humphries KH, Webb JG, Scacciatella P, Grasso C, D'Amico M, Biondi-Zoccai G, Gaita F, Marra S. A meta-analysis of sex-related differences in outcomes after primary percutaneous intervention for ST-segment elevation myocardial infarction. J Interv Cardiol. 2015;28(2):132–40.CrossRefPubMed

17.

Bundhun PK, Wu ZJ, Chen MH. Impact of modifiable cardiovascular risk factors on mortality after percutaneous coronary intervention: a systematic review and meta-analysis of 100 studies. Medicine (Baltimore). 2015;94(50):e2313.CrossRef

18.

Albertal M, Cura F, Escudero AG, Thierer J, Trivi M, Padilla LT, Belardi J, PREMIAR investigators. Mechanism involved in the paradoxical effects of active smoking following primary angioplasty: a subanalysis of the protection of distal embolization in high-risk patients with acute myocardial infarction trial. J Cardiovasc Med (Hagerstown). 2008;9(8):810–2.CrossRef

19.

Weisz G, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey TD, Rutherford BD, Mehran R, Aymong E, Lansky A, Grines CL, Stone GW. Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction--the smoker's paradox revisited. Am Heart J. 2005;150(2):358–64.CrossRefPubMed

20.

Lee C, Joseph L, Colosimo A, Dasgupta K. Mortality in diabetes compared with previous cardiovascular disease: a gender-specific meta-analysis. Diabetes Metab. 2012;38(5):420–7.CrossRefPubMed

21.

Steinberg HO, Paradisi G, Cronin J, Crowde K, Hempfling A, Hook G, Baron AD. Type II diabetes abrogates sex differences in endothelial function in premenopausal women. Circulation. 2000;101(17):2040–6.CrossRefPubMed

22.

Mortensen KH, Thuesen L, Kristensen IB, Christiansen EH. Spontaneous coronary artery dissection: a western Denmark heart registry study. Catheter Cardiovasc Interv. 2009;74(5):710–7.CrossRefPubMed

23.

Vaccarino V, Badimon L, Corti R, de Wit C, Dorobantu M, Hall A, Koller A, Marzilli M, Pries A, Bugiardini R. Working group on coronary Pathophysiologyand microcirculation. Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position paper from the working group on coronary pathophysiology and microcirculation of the European society of cardiology. Cardiovasc Res. 2011;90(1):9–17.CrossRefPubMed

24.

Jacobs AK. Coronary intervention in 2009: are women no different than men? Circ Cardiovasc Interv. 2009;2(1):69–78.CrossRefPubMed

25.

Graham MM, Ghali WA, Faris PD, Galbraith PD, Norris CM, Knudtson ML. APPROACH Investigators. Sex differences in the prognostic importance of diabetes in patients with ischemic heart disease undergoing coronary angiography. Diabetes Care. 2003;26(11):3142–7.CrossRefPubMed

26.

Buja P, D'Amico G, Facchin M, Barioli A, Napodano M, Capodanno D, Musumeci G, Frigo AC, Saia F, Menozzi A, De Benedictis M, Lee MS, Lettieri C, Tamburino C, Sardella G, Isabella G, Tarantini G. Gender-related differences of diabetic patients undergoing percutaneous coronary intervention with drug-eluting stents: a real-life multicenter experience. Int J Cardiol. 2013;168(1):139–43.CrossRefPubMed

27.

Lin GM, Li YH, Lin CL, Wang JH, Han CL. Gender differences in the impact of diabetes on mortality in patients with established coronary arterydisease: a report from the eastern Taiwan integrated health care delivery system of coronary heart disease(ET-CHD) registry, 1997-2006. J Cardiol. 2013;61(6):393–8.CrossRefPubMed

28.

Younan H, Ragab T, El-Khashab K, Farag N. Impact of gender difference on PCI outcome in Egyptian diabetic patients: prospective two center registry study. Egypt Heart J. 2015;67(1):55–61. http://dx.doi.org/10.1016/j.ehj.2014.09.001.

29.

Epps KC, Holper EM, Selzer F, Vlachos HA, Gualano SK, Abbott JD, Jacobs AK, Marroquin OC, Naidu SS, Groeneveld PW, Wilensky RL. Sex differences in outcomes following percutaneous coronary intervention according to age. Circ Cardiovasc Qual Outcomes. 2016;9(2 Suppl 1):S16–25.CrossRefPubMedPubMedCentral

30.

Toyota T, Furukawa Y, Ehara N, Funakoshi S, Morimoto T, Kaji S, Nakagawa Y, Kadota K, Iwabuchi M, Shiomi H, Yamamuro A, Kinoshita M, Kitai T, Kim K, Tani T, Kobori A, Kita T, Sakata R, Kimura T. Credo-Kyoto Investigators. Sex-based differences in clinical practice and outcomes for Japanese patients with acute myocardialinfarction undergoing primary percutaneous coronary intervention. Circ J. 2013;77(6):1508–17.CrossRefPubMed

31.

Cheng CI, Yeh KH, Chang HW, Yu TH, Chen YH, Chai HT, Yip HK. Comparison of baseline characteristics, clinical features, angiographic results, and early outcomes in men vs women with acute myocardial infarction undergoing primary coronary intervention. Chest. 2004;126(1):47–53.CrossRefPubMed

32.

Eitel I, Desch S, de Waha S, Fuernau G, Gutberlet M, Schuler G, Thiele H. Sex differences in myocardial salvage and clinical outcome in patients with acute reperfused ST-elevation myocardial infarction: advances in cardiovascular imaging. Circ Cardiovasc Imaging. 2012;5(1):119–26.CrossRefPubMed

33.

Kosuge M, Kimura K, Kojima S, Sakamoto T, Ishihara M, Asada Y, Tei C, Miyazaki S, Sonoda M, Tsuchihashi K, Yamagishi M, Ikeda Y, Shirai M, Hiraoka H, Inoue T, Saito F, Ogawa H. Japanese acute coronary syndrome study (JACSS) investigators. Sex differences in early mortality of patients undergoing primary stenting for acute myocardial infarction. Circ J. 2006;70(3):217–21.CrossRefPubMed

34.

Zhang Q, Qiu JP, Zhang RY, Li YG, He B, Jin HG, Zhang JF, Wang XL, Jiang L, Liao ML, Hu J, Shen WF. Absence of gender disparity in short-term clinical outcomes in patients with acute ST-segment elevationmyocardial infarction undergoing sirolimus-eluting stent based primary coronary intervention: a report from shanghai acute coronary event (SACE) registry. Chin Med J. 2010;123(7):782–8.PubMed

35.

Zanchi J, Mirić D, Giunio L, Vuković I, Marković B, Duplancić D, Kristić I. Gender differences in in-hospital mortality and angiographic findings of patients with acute ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI). Coll Antropol. 2009;33(4):1359–62.PubMed

Title: Are women with type 2 diabetes mellitus more susceptible to cardiovascular complications following coronary angioplasty?: a meta-analysis
Authors: Pravesh Kumar Bundhun
Manish Pursun
Feng Huang
Publication date: 01-12-2017
Publisher: BioMed Central
Published in: BMC Cardiovascular Disorders / Issue 1/2017
Electronic ISSN: 1471-2261
DOI: https://doi.org/10.1186/s12872-017-0645-8

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Are women with type 2 diabetes mellitus more susceptible to cardiovascular complications following coronary angioplasty?: a meta-analysis

Abstract

Background

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2017

Deletion of the NR4A nuclear receptor NOR1 in hematopoietic stem cells reduces inflammation but not abdominal aortic aneurysm formation

Variability of radiation doses of cardiac diagnostic imaging tests: the RADIO-EVINCI study (RADIationdOse subproject of the EVINCI study)

Statin use reduces cardiovascular events and all-cause mortality amongst Chinese patients with type 2 diabetes mellitus: a 5-year cohort study

Approach selection of radiofrequency catheter ablation for ventricular arrhythmias originating from the left ventricular summit: potential relevance of Pseudo Delta wave, Intrinsicoid deflection time, maximal deflection index

Mediterranean dietary quality index and dietary phytochemical index among patients candidate for coronary artery bypass grafting (CABG) surgery

Can coefficient of variation of time-domain analysis be valuable for detecting cardiovascular autonomic neuropathy in young patients with type 1 diabetes: a case control study

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page